Cancer screening aims to detect cancer before symptoms appear
It spots cancer at an early stage, when treatment is more likely to be successful.The importance of early cancer detection
people develop cancer in their lifetime
%
of cancers are diagnosed late
Early diagnosis doubles cancer survival
Major cancer type 5-year survival rate by stage detected
Stage 1
Stage 4
Lung
- Lung stage 1 60%
- Lung stage 4 6%
Prostate
- Prostate stage 1 100%
- Prostate stage 4 31%
Colorectal
- Colo stage 1 91%
- Colo stage 4 15%
Breast
- Breat stage 1 99%
- Breast stage 4 29%
Why Flomics?
Flomics’ flagship product is a multi-cancer liquid biopsy test. It looks for disease–associated patterns in the expression of RNA molecules that circulate in our blood.
Our genomics experts combine Next-Generation Sequencing (NGS) of RNA biomarkers with powerful bioinformatics techniques. We develop a novel non-invasive screening test, providing actionable information in the much-needed early-stage cancer detection field.
The Future of Diagnostics
An earlier and accurate diagnosis would have massive benefits to the patients’ quality of life. Treatment could commence earlier, improving the chance of a favourable outcome and minimizing the time and discomfort lost to sickness.
